Elderly Metastatic Breast Cancer: Pertuzumab-Herceptin vs Pertuzumab-Herceptin-Metronomic Chemotherapy, Followed by T-DM1

NCT01597414 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

NETWORK

Sponsor class

Conditions

Elderly Metastatic Breast Cancer Population

Interventions

DRUG: Pertuzumab + trastuzumab
DRUG: Pertuzumab + trastuzumab + metronomic chemotherapy

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC

Collaborators

[object Object]